Castle Creek Arbitrage’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Castle Creek Arbitrage’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-32,043	Closed	-$324K	–	565
2022 Q4	$324K	Buy	+32,043	New	+$320K	0.03%	223

Castle Creek Arbitrage's EBAC Position: Q1 2023 in Review

Castle Creek Arbitrage sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 32,043 shares — an estimated $324K sold.

Castle Creek Arbitrage first reported a position in EBAC in Q4 2022 and held it in 1 quarter. The position peaked at $324K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

Castle Creek Arbitrage reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 32,043 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $324K.
Castle Creek Arbitrage first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q4 2022 and held it in 1 quarter.
Castle Creek Arbitrage's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $324K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Castle Creek Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.